Create a free QxMD account to take advantage of the features offered by Read like saving your papers and creating collections.

Get Started

COMMENT

JOURNAL ARTICLE

Fibroblast growth factor 23 and uremic vascular calcification: is it time to escalate from biomarker status to pathogenic agent?

Orson W Moe, Makoto Kuro-o

Kidney International 2014, 85 (5): 1022-3

Although epidemiologic associations have been informative, the elucidation of the role of fibroblast growth factor 23 (FGF23) in chronic kidney disease (CKD) requires testing with robust experimental models. Jimbo et al. used animal and cell-culture models to query whether FGF23 is a direct 'vasculotoxin.' We discuss the interpretation of their findings. At this juncture, much remains unanswered about the significance of FGF23 elevation in CKD.

Full Text Links

Find Full Text Links for this Article

Discussion

You are not logged in. Sign Up or Log In to join the discussion.

Related Papers

Fibroblast growth factor 23 accelerates phosphate-induced vascular calcification in the absence of Klotho deficiency. Rika Jimbo, Fumiko Kawakami-Mori, Shengyu Mu, Daigoro Hirohama, Bohumil Majtan, Yuichiro Shimizu, Yutaka Yatomi, Seiji Fukumoto, Toshiro Fujita, Tatsuo Shimosawa Kidney International 2014, 85 (5): 1103-11

Fibroblast growth factor 23 is not associated with and does not induce arterial calcification. Julia J Scialla, Wei Ling Lau, Muredach P Reilly, Tamara Isakova, Hsueh-Ying Yang, Matthew H Crouthamel, Nicholas W Chavkin, Mahboob Rahman, Patricia Wahl, Ansel P Amaral, Takayuki Hamano, Stephen R Master, Lisa Nessel, Boyang Chai, Dawei Xie, Radhakrishna R Kallem, Jing Chen, James P Lash, John W Kusek, Matthew J Budoff, Cecilia M Giachelli, Myles Wolf Kidney International 2013, 83 (6): 1159-68

Vitamin D receptor agonists increase klotho and osteopontin while decreasing aortic calcification in mice with chronic kidney disease fed a high phosphate diet. Wei Ling Lau, Elizabeth M Leaf, Ming Chang Hu, Marc M Takeno, Makoto Kuro-o, Orson W Moe, Cecilia M Giachelli Kidney International 2012, 82 (12): 1261-70

Vascular Klotho deficiency potentiates the development of human artery calcification and mediates resistance to fibroblast growth factor 23. Kenneth Lim, Tzong-Shi Lu, Guerman Molostvov, Christina Lee, F T Lam, Daniel Zehnder, Li-Li Hsiao Circulation 2012 May 8, 125 (18): 2243-55

Overexpression of c1q/tumor necrosis factor-related protein-3 promotes phosphate-induced vascular smooth muscle cell calcification both in vivo and in vitro. Yun Zhou, Jin-Yu Wang, Han Feng, Cheng Wang, Li Li, Dan Wu, Hong Lei, Hao Li, Li-Ling Wu Arteriosclerosis, Thrombosis, and Vascular Biology 2014, 34 (5): 1002-10

FGF23 is independently associated with vascular calcification but not bone mineral density in patients at various CKD stages. L Desjardins, S Liabeuf, C Renard, A Lenglet, H-D Lemke, G Choukroun, T B Drueke, Z A Massy Osteoporosis International 2012, 23 (7): 2017-25

p53 negatively regulates the osteogenic differentiation of vascular smooth muscle cells in mice with chronic kidney disease. K L Li, J Chen, Z H Li, L Zhao, Y N He Cardiovascular Journal of Africa 2012, 23 (6): e1-9

Direct, acute effects of Klotho and FGF23 on vascular smooth muscle and endothelium. Isabelle Six, Hirokazu Okazaki, Priscilla Gross, Joanna Cagnard, Cédric Boudot, Julien Maizel, Tilman B Drueke, Ziad A Massy PloS One 2014, 9 (4): e93423

Effect of water fluoridation on the development of medial vascular calcification in uremic rats. Ana Martín-Pardillos, Cecilia Sosa, Ángel Millán, Víctor Sorribas Toxicology 2014 April 6, 318: 40-50

Autophagy and matrix vesicles: new partners in vascular calcification. Catherine M Shanahan Kidney International 2013, 83 (6): 984-6

Make the most of Read.
Download the mobile app.

Want full text access to this paper?

Use Read by QxMD to access full text via your institution or open access sources.

Read also provides personalized recommendations to keep you up to date in your field.

Existing User

New to Read

Fibroblast growth factor 23 and uremic vascular calcification: is it time to escalate from biomarker status to pathogenic agent?

Discussion

Related Papers

Want full text access to this paper?

Save your favorite articles in one place with a free QxMD account.

Read

Search Tips